Accelerate to discover
Related topics
Webinar recording: Isolating ultra-high molecular weight (UHMW) DNA for genome analysis
May 12, 2020
Watch the webinar from Bionano Genomics and learn the tips and tricks for isolating high quality UHMW DNA - right from...
Isoflux webinar: Accurate liquid biopsy approach reveals mutations in lung cancer patients
Apr 29, 2020
Liquid biopsies aim to identify clinically actionable information from cell-free DNA (cfDNA) and circulating tumor...
Panel design principles to investigate COVID-19 immune response with the Cytek Aurora
Apr 27, 2020
Learn about the Cytek Aurora and panel design tools available to help you design high quality full spectrum cytometry...
Ensuring Quantitative Accuracy in PET webinar
Apr 14, 2020
Image quality is only one aspect of functional imaging with PET and SPECT and the ability to reproducibly extract...
xCELLigence system: rapid and sensitive, ideal for infectious viral assays.
Mar 30, 2020
As the public health threat from COVID-19 and future emergent viruses continue to persist, the rapid, sensitive, and...
IncuCyte webinar: Organoids, iPSCs, and advanced cell models.
Mar 24, 2020
Researchers are now moving from reductionist, 2D monoculture assay models to more complex 3D cell models, such as...
Webinar recording: Metabolic MR Imaging of Obesity
Mar 24, 2020
The study of fat distribution is important to understand the pathophysiology of obesity related disorders, diabetes...
Webinar recording: Ex vivo microangioCT, advances in microvascular imaging
Mar 16, 2020
A new technique called microangioCT imaging is being used with a novel polymerizing contrast agent that enables 3D...
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
